Indobufen is a reversible platelet aggregation inhibitor and non-steroidal anti-inflammatory drug (NSAID) primarily used to manage thromboembolic disorders and reduce inflammatory pain. By reversibly inhibiting… Read more
Indobufen is a reversible platelet aggregation inhibitor and non-steroidal anti-inflammatory drug (NSAID) primarily used to manage thromboembolic disorders and reduce inflammatory pain. By reversibly inhibiting the cyclooxygenase enzyme, it suppresses thromboxane and prostaglandin synthesis, which helps prevent arterial thrombosis and alleviate symptoms associated with inflammatory conditions. This category includes a comprehensive range of related compounds, such as synthesis impurities, metabolites, and stable isotope labelled standards. These high-quality reference standards are essential for laboratories performing rigorous impurity profiling, method validation, and quality control of the active pharmaceutical ingredient. Chemists and researchers utilize these compounds to ensure analytical accuracy, support stability testing, and meet stringent regulatory requirements for pharmaceutical analysis.